Agilent's HPLC-Chip/MS technology helps identify over 200 different human milk oligosaccharides structures

Agilent Technologies Inc. (NYSE:A) today announced that a group of researchers from the University of California, Davis, has made a significant discovery: human breast milk contains an unexpected abundance of sugars that coats the lining of infants' intestines, protecting it from noxious bacteria. Results of the research, which used Agilent technology, were published in this month's Proceedings of the National Academy of Sciences of the United States of America.

“However, the new technology developed by Agilent made it possible to identify and quantitate milk oligosaccharides providing new and important observations that could not be obtained in the past.”

Agilent's high-performance liquid chromatography polymer chip (HPLC-Chip) and quadrupole time-of-flight (QTOF) LC/MS technology provided researchers a new view of the oligosaccharide (sugar) structures produced in breast milk across stages of lactation among human mothers. Oligosaccharides are the third most abundant component in breast milk and prior to this study were thought to have no biological significance. HPLC-Chip/MS technology has enabled researchers to identify more than 200 different human milk oligosaccharides structures, which researchers have discovered are an important factor in the healthy growth of infants.

"This type of research has been performed and duplicated many times in the past," said Dr. Carlito B. Lebrilla, co-author of the research. "However, the new technology developed by Agilent made it possible to identify and quantitate milk oligosaccharides providing new and important observations that could not be obtained in the past."

Agilent commercialized the HPLC-Chip/MS concept in 2005, combining nanoflow HPLC columns, connecting capillaries and a spray emitter into a re-useable, credit-card-size device. This allowed the advantages of high-sensitivity and low-sample consumption provided by nano LC/MS to be accessible to scientists without the troublesome setup involving microvalve, fittings and capillary tubing of conventional nano LC. The addition of high-resolution, accurate mass MS/MS information from Agilent's 6500-Series Q-TOF LC/MS systems enabled researchers to confidently identify sugar structures.

"This is truly a remarkable study, providing answers to questions many in the scientific community have been researching for decades," said Rudi Grimm, Ph.D., director of science and technology for Agilent's Life Sciences Group. "As a leading partner to the academic community, we are both excited and pleased that our technology enabled this breakthrough research."

SOURCE Agilent Technologies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Utilizing process Raman in optimizing cultivated meat production